Skip to content
hcg-service-hero-1

Insights From Halloran

Meghan Patterson, MPHNov 2, 2023 12:00:00 AM3 min read

How to Fix What’s Broken with Clinical Trial Compensation

What is broken at clinical research sites? This question posed at CORE East, a three-day ...
Start Reading
Meghan Patterson, MPHOct 24, 2023 11:15:00 AM4 min read

Revolutionizing Clinical Trials: A Patient-Centric Approach for a Better Tomorrow

In the vast landscape of clinical research, patients stand as the primary stakeholders, ...
Start Reading
Rachel LarmandOct 19, 2023 3:48:00 PM5 min read

This is How We Positively Disrupt Clinical Research

Life science executives recently convened in Chatham, Massachusetts, for the 15th annual ...
Start Reading
Steve Kornher, PhDOct 3, 2023 3:00:00 PM17 min read

Raw Materials Control for Biotechs (Part 1): Pre-Clinical Development Considerations

The product development stage, commonly referred to as pre-clinical development, precedes ...
Start Reading
Halloran Consulting GroupSep 15, 2023 3:36:00 PM2 min read

Are You Planning for Success? Essential Role of the Program Manager 

Small life science companies often need to ‘do more with less.’ Leaders of these ...
Start Reading
Carolina Ahrendt, MBA, PMPSep 14, 2023 1:46:00 PM2 min read

Turning Drug Development Chaos into Order for an NDA

Read our latest Case Study Turning Drug Development Chaos into Order for an NDA Situation
Start Reading
Halloran Consulting GroupSep 7, 2023 4:39:00 PM5 min read

So, You Have Veeva! Four Tips to Maximize Your Value

The use of Veeva systems, a suite of clinical trial solutions, continues to grow. Veeva’s ...
Start Reading
Lyn AgostinelliAug 23, 2023 3:37:00 PM4 min read

Risk-Based Approach to Monitoring of Clinical Investigations – Halloran’s Review of FDA’s Guidance

In April of 2023, the U.S Food and Drug Administration (FDA) released “A Risk-Based ...
Start Reading
Halloran Consulting GroupAug 15, 2023 10:27:00 AM7 min read

How Strong Project Management Propels Clinical Development Success

The Cost and Challenges of Drug Development
Start Reading
Halloran Consulting GroupAug 3, 2023 4:41:00 PM6 min read

Halloran’s View on FDA’s Draft Guidance on Psychedelic Drugs

The U.S. Food and Drug Administration (FDA) recently issued a draft guidance for industry ...
Start Reading